4P-Phar­ma rais­es €15M; On­cotel­ic Ther­a­peu­tics sells rights to can­cer as­sets

Plus, news about Adap­tilens:

4P-Phar­ma se­cures €15M in sec­ond clos­ing: The fundraise, which was backed by pri­vate …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.